paperKB
coga / coga-kb
Help
Sign in

Chunk #108 — Clinical Considerations: Comorbidities of SUD and Implications for Individualized (qEEG-Guided) Neurofeedback

Source
EEG biofeedback as a treatment for substance use disorders: review, rating of efficacy, and recommendations for further research.
Embedded
yes

Text

amplitude is associated with anxiety, insomnia, and alcohol/drug abuse. Central abnormalities are interpreted as mesial frontal dysfunction and are associated with anxiety, rumination, and obsessive compulsive symptoms. The therapeutic approach is to base neurotherapy on correcting identified qEEG abnormalities, i.e., train beta excess amplitude down when present, while monitoring symptoms.